Signed in as:
filler@godaddy.com
Bringing awareness of current trends and updates on government regulations and changes in the Canadian pharmaceutical and healthcare industry.
Providing members with an opportunity to learn in both a formal and informal setting about the practical skills and knowledge relating to our industry, profession, and market.
Bringing members together to facilitate networking with other life science professionals, provide business opportunities and celebrate each other's accomplishments.
Jeff Doan is the Founder / Director of Client Services at Stanley Park Group. With over 20 years of experience in the pharmaceutical industry, Jeff brings extensive commercial knowledge and insight to every situation and client we work with. Dedicated to the industry, Jeff is a needs-based solution generator, consistently bringing innov
Jeff Doan is the Founder / Director of Client Services at Stanley Park Group. With over 20 years of experience in the pharmaceutical industry, Jeff brings extensive commercial knowledge and insight to every situation and client we work with. Dedicated to the industry, Jeff is a needs-based solution generator, consistently bringing innovative ideas to your project. Jeff is the incoming President of the CHLA.
Michael Bethell leads Fernbank, a specialty consulting organization in Life Sciences based in Toronto. He has extensive experience in injectable pharmaceuticals with a focus on the institutional markets in North America and European sourcing. He has successfully lead projects in API sourcing, the manufacturing and distribution process,
Michael Bethell leads Fernbank, a specialty consulting organization in Life Sciences based in Toronto. He has extensive experience in injectable pharmaceuticals with a focus on the institutional markets in North America and European sourcing. He has successfully lead projects in API sourcing, the manufacturing and distribution process, and improving process flow with HCPs. Michael has effected multiple strategic transactions in Canada, the United States, and in Europe. In addition, he has built and operated class-leading businesses in specialty pharma in Canada.
Lyanne Winikoff is a partner at Greenspoon Winikoff LLP a Montreal based law firm. Lyanne practices in the area of corporate and commercial law and has a particular expertise in the fields of biotechnology and pharmaceutical law, information technology and intellectual property. She has extensive experience representing private and publi
Lyanne Winikoff is a partner at Greenspoon Winikoff LLP a Montreal based law firm. Lyanne practices in the area of corporate and commercial law and has a particular expertise in the fields of biotechnology and pharmaceutical law, information technology and intellectual property. She has extensive experience representing private and public companies in a wide variety of corporate and commercial transactions, including mergers and acquisitions, private placements, licensing and distribution agreements, co-promotion arrangements, technology transfers and research and development collaborations.
Tim Hendrickson is the Chief Financial Officer at HLS Therapeutics. He has been a long standing member of the association. He was formerly an executive with Cubist Pharmaceuticals through its acquisition by Merck & Co in early 2015. Tim is a financial executive with over 15 years of experience at companies such as Procter & Gamble, P
Tim Hendrickson is the Chief Financial Officer at HLS Therapeutics. He has been a long standing member of the association. He was formerly an executive with Cubist Pharmaceuticals through its acquisition by Merck & Co in early 2015. Tim is a financial executive with over 15 years of experience at companies such as Procter & Gamble, P&G Pharmaceuticals and Warner Chilcott. He has held leadership roles in finance & accounting, forecasting & financial analysis, business development & planning, customer service, distribution and operations.